Maxwell S A, Arlinghaus R B
J Gen Virol. 1985 Oct;66 ( Pt 10):2135-46. doi: 10.1099/0022-1317-66-10-2135.
Two proteins, termed P85gag-mos and P58gag, are encoded by the temperature-sensitive transformation mutant, ts110 Moloney murine sarcoma virus (MuSV). Based on temperature-shift studies, P85gag-mos is believed to be important for the transforming potential of ts110 MuSV and has been found to be associated with a thermolabile kinase activity that phosphorylates both P85gag-mos and P58gag in immune complexes. Modifications of the original kinase assay conditions are reported here that have allowed a 30-fold increase in the specific activity of P85gag-mos phosphorylated in vitro. The in vitro P85gag-mos-phosphorylating activity was found to be unresponsive to 10 microM-cAMP or 10 microM-cGMP. Addition of 1 mM-pyrophosphate, a known phosphatase inhibitor, to the reaction mixture resulted in an increased yield of phosphorylated P85gag-mos and P58gag; the molar phosphate incorporation per mole of P85gag-mos increased from 0.032 to 0.9, whereas the specific activity of in vitro-phosphorylated P58gag increased 18-fold, from 0.013 to 0.234. pH curves of the in vitro kinase reaction further confirmed the presence of phosphatase activity; in the absence of pyrophosphate, a sharp optimum at pH 4 to 5 was observed, whereas it shifted broadly to pH 7.0 in the presence of pyrophosphate. Under the latter conditions, several experiments were performed in order to determine if the kinase was associated with either gag or mos sequences of P85gag-mos. Antisera directed against p15, p12 and p30 sequences of the gag protein region of P85gag-mos yielded immune complexes that allowed phosphorylation in vitro of P85gag-mos. No phosphorylating activity was detected in immune complexes containing MuSV-124-encoded P62gag. An anti-mos serum generated against a synthetic peptide representing the predicted v-mos amino acid residues 37 to 55 recognizes P85gag-mos and allowed phosphorylation of P85gag-mos in vitro in the absence of P58gag. Peptide mapping of both phosphorylated P85gag-mos and P58gag, by using a combination of Cleveland and Western/immunoperoxidase techniques, demonstrated that P85gag-mos became phosphorylated not only on gag sequences, but also at the N-terminal portion of v-mos. Phosphoamino acid analyses of P85gag-mos and P58gag phosphorylated in vitro under these modified conditions yielded predominantly phosphoserine and lesser amounts of phosphothreonine. Metabolically 32P-labelled P85gag-mos and P58gag were also found to contain phosphoserine and phosphothreonine. Based on these results, we conclude that a cAMP-independent, serine/threonine protein kinase activity is associated with the mos sequences of P85gag-mos.
温度敏感型转化突变体ts110莫洛尼氏鼠肉瘤病毒(MuSV)编码两种蛋白质,分别称为P85gag-mos和P58gag。基于温度转换研究,P85gag-mos被认为对ts110 MuSV的转化潜能很重要,并且已发现它与一种热不稳定激酶活性相关,该活性可在免疫复合物中使P85gag-mos和P58gag磷酸化。本文报道了对原始激酶测定条件的改进,这些改进使体外磷酸化的P85gag-mos的比活性提高了30倍。发现体外P85gag-mos磷酸化活性对10微摩尔/升的cAMP或10微摩尔/升的cGMP无反应。向反应混合物中添加1毫摩尔/升的焦磷酸(一种已知的磷酸酶抑制剂)可提高磷酸化的P85gag-mos和P58gag的产量;每摩尔P85gag-mos掺入的磷酸盐摩尔数从0.032增加到0.9,而体外磷酸化的P58gag的比活性从0.013增加了18倍,达到0.234。体外激酶反应的pH曲线进一步证实了磷酸酶活性的存在;在没有焦磷酸的情况下,观察到在pH 4至5时有一个尖锐的最佳值,而在有焦磷酸的情况下,它广泛地转移到pH 7.0。在后者的条件下,进行了几项实验以确定该激酶是否与P85gag-mos的gag或mos序列相关。针对P85gag-mos的gag蛋白区域的p15、p12和p30序列的抗血清产生了免疫复合物,该复合物可使P85gag-mos在体外磷酸化。在含有MuSV-124编码的P62gag的免疫复合物中未检测到磷酸化活性。针对代表预测的v-mos氨基酸残基37至55的合成肽产生的抗mos血清识别P85gag-mos,并在没有P58gag的情况下使P85gag-mos在体外磷酸化。通过结合克利夫兰和蛋白质免疫印迹/免疫过氧化物酶技术对磷酸化的P85gag-mos和P58gag进行肽图谱分析,表明P85gag-mos不仅在gag序列上磷酸化,而且在v-mos的N末端部分也磷酸化。在这些改良条件下体外磷酸化的P85gag-mos和P58gag的磷酸氨基酸分析主要产生磷酸丝氨酸,磷酸苏氨酸的量较少。代谢性32P标记的P85gag-mos和P58gag也被发现含有磷酸丝氨酸和磷酸苏氨酸。基于这些结果,我们得出结论,一种不依赖cAMP的丝氨酸/苏氨酸蛋白激酶活性与P85gag-mos的mos序列相关。